Navigation Links
Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
Date:3/28/2008

- Company Plans to Request Timely Hearing before a NASDAQ Listing

Qualifications Panel -

FREMONT, Calif., March 28 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML, VRMLD) (the "Company"), a molecular diagnostics company, announced today that on March 18, 2008, the Company received communication from The NASDAQ Stock Market ("NASDAQ") that, as a result of the Company's common stock closing at $1.00 per share or more for a minimum of 10 consecutive business days, it has achieved compliance with the minimum bid price requirement for continued listing set forth in NASDAQ Marketplace Rule 4310(c)(4) ("Rule 4310(c)(4)").

The communication follows a notice of noncompliance from NASDAQ dated September 6, 2007, which was disclosed by the Company on September 7, 2007, that indicated that the Company failed to comply with the minimum bid price requirement for continued listing set forth in Rule 4310(c)(4). The notice of noncompliance gave the Company notice that the bid price of its common stock had closed under $1.00 per share for the previous 30 business days, and stated that if the Company could not demonstrate compliance with Rule 4310(c)(4) by March 4, 2008, the NASDAQ staff would determine whether or not the Company meets The NASDAQ Capital Market initial listing criteria set forth in NASDAQ Marketplace Rule 4310(c), except for the bid price requirement.

The bid price requirement was met in part as a result of the 1-for-10 reverse stock split of the Company's outstanding common stock effected by the filing of the Company's Third Amended and Restated Certificate of Incorporation on February 29, 2008, which was disclosed by the Company on March 3, 2008. The reverse stock split was effec
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. World Think Tank on Type 1 Diabetes Meets in Miami
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ ... help predict the adverse and therapeutic effects of a ... Computational Biology at the Genomics Laboratory, Covance, will discuss ... genomics when used as part of the QC process. ... sets to identify key clinical targets even in complex ...
(Date:5/17/2013)... WA (PRWEB) May 17, 2013 Tooth decay ... graders showing active signs of the disease. The World Health ... and nearly 100% of adults have cavities. What are the ... is showing a strong connection between the oral bacterial ... is this disease so rampant, yet it is also 100% ...
(Date:5/16/2013)... Zealand (PRWEB) May 16, 2013 In late ... invited to speak to doctors in China about Appearance ... and NZ, this was her first trip to lecture in ... Hart visited Guangzhou and Fuzhou, home to 12 and 7 ... China is very high at this point in time. As ...
(Date:5/16/2013)... PORTLAND, Ore. , May 16, 2013 /PRNewswire/ ... to many of the nation,s largest regional health ... the America,s Health Insurance Plans (AHIP) Institute 2013 ... and highlight survey results showing how health insurance ... planning for the consumer and marketplace demands for ...
Breaking Biology Technology:Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3
... the H1N1 flu virus, could help to ease future vaccine ... with the flu virus. In a study published ... Breath Research , researchers have investigated an easy, non-invasive breath ... H1N1 strain. Research published last month claimed that ...
... 14, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, for ... 1/2 trial for BMN 673 for the treatment of patients ... ongoing. "We are excited to be at ...
... Quest Diagnostics (NYSE: DGX ), ... and services, and Genomic Vision, a biotechnology company dedicated ... a multi-year exclusive collaboration involving Genomic Vision,s proprietary ... terms of the agreement, Quest Diagnostics has exclusive ...
Cached Biology Technology:'Swine flu' breath test could reduce future vaccination shortages, research suggests 2BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies 2BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies 3Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests 2Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests 3Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests 4
(Date:5/16/2013)... shown a gene involved in neurodegenerative disease also plays ... circadian clock. , In a study of the ... Ataxin-2, keeps the clock responsible for sleeping and waking ... of the fruit fly,s sleep-wake cycle is disturbed, making ... fly. , The discovery is particularly interesting because ...
(Date:5/16/2013)... The endothelium, the cellular layer lining the body,s ... few hundred nanometers in thickness, this super-tenuous structure ... tissue compression to create a unique and highly ... partition tissues from the body,s circulatory system. , ... barrier must be physically breached to enable ...
(Date:5/16/2013)... sports players and athletes choose to wear the color ... published in Psychological Science , a journal of ... have to do with their testosterone levels. , The ... the University of Sunderland and colleagues, demonstrated that males ... task had higher testosterone levels than other males who ...
Breaking Biology News(10 mins):Gene involved in neurodegeneration keeps clock running 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4High-testosterone competitors more likely to choose red 2
... A massive, growing pool of icy meltwater in the Arctic ... researchers said today. Estimated in 2009 at more ... Africa,s Lake Victoria and growing, the water could flush ... patterns shift, as occurred most recently in the 1960s and ...
... -- Sealants, like weather stripping, are what separates the ... barrier that prevents water from seeping in, for example, ... chemist Christopher White of the National Institute of Standards ... they will fail. Current methods test sealants statically, ...
... release is available in Spanish . ... at the XXVI National Congress on Human Genetics held in ... concretely, it is based on microarray technology (genomic hybridisation genetic ... the common cytogenetic techniques. The new device, known as Amniochip, ...
Cached Biology News:Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 2Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 3Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 4Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 5Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 6Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 7Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 8Inexpensive new instruments test building sealants under real-world conditions 2New technology capable of detection of 150 genetic syndromes from an amniocentesis 2
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
Experion HighSens chips are the microfluidic chips used to perform high-sensitivity RNA analysis (picogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to ru...
...
...
Biology Products: